Immune-mediated myocarditis in Fabry disease cardiomyopathy causes disease progression and resistance to enzyme replacement therapy. Influence of immunosuppressive therapy
- 4 Anni 2019/2023
- 160.500€ Totale Fondi
Abstract non disponibile
Pubblicazioni Scientifiche
-
Divergent Impact of Enzyme Replacement Therapy on Human Cardiomyocytes and Enterocytes Affected by Fabry Disease: Correlation with Mannose-6-phosphate Receptor Expression
-
Downregulation of Mannose-6-Phosphate Receptors in Fabry Disease Cardiomyopathy: A Potential Target for Enzyme Therapy Enhancement
-
Immune-Mediated Myocarditis in Fabry Disease Cardiomyopathy
-
Hypertrophy of unafected cardiomyocytes correlates with severity of cardiomyopathy in female patients with Fabry disease
